September 29, 2025

Revolution Medicines, Inc. (RVMD) Investor Outlook: Analyzing a 71.84% Potential Upside with Strong Buy Ratings

Revolution Medicines, Inc. (NASDAQ: RVMD), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to treating RAS-addicted cancers. Specializing in precision oncology, this Redwood..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unveiling a 31.49% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH) is a significant player in the healthcare sector, specializing in the development and distribution of over-the-counter (OTC) health and personal care products across the..

Incyte Corporation (INCY) Stock Analysis: Insights into Growth and Analyst Ratings

Incyte Corporation (NASDAQ: INCY) has carved a niche in the biotechnology sector with its innovative biopharmaceutical solutions. As a prominent player in healthcare, Incyte is engaged in the discovery, development,..

Guardant Health, Inc. (GH) Stock Analysis: Navigating the Precision Oncology Frontier with Promising 11.76% Upside

Guardant Health, Inc. (GH), a trailblazer in precision oncology, is capturing investor attention with its innovative approach to cancer diagnostics and a notable potential upside of 11.76%. As a player..

DexCom, Inc. (DXCM) Stock Analysis: Significant Upside with a 50.77% Growth Potential

DexCom, Inc. (NASDAQ: DXCM), a leader in the medical devices sector, continues to capture investor attention with its innovative continuous glucose monitoring (CGM) systems. With a market capitalization of $26.31..

Tempus AI, Inc. (TEM) Stock Analysis: Navigating Growth with a 89.6% Revenue Surge in Healthcare

Tempus AI, Inc. (TEM), a prominent player in the healthcare technology sector, has caught the attention of investors with its impressive growth metrics and strategic collaborations. Based in Chicago, Illinois,..

Stevanato Group S.p.A. (STVN): An Investor Outlook on Its 11.57% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, is drawing the attention of investors with its significant growth prospects and a strategic footprint in the medical..

Henry Schein, Inc. (HSIC) Stock Analysis: A Closer Look at Growth Potential and Market Position

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. Headquartered in Melville, New York, the company holds a market..

Veeva Systems Inc. (VEEV) Stock Analysis: 9% Potential Upside in the Healthcare Sector

Investors eyeing the healthcare technology sector might want to take a closer look at Veeva Systems Inc. (NYSE: VEEV), a prominent player in providing cloud-based software solutions tailored for the..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 23.42% Upside Potential

Takeda Pharmaceutical Company Limited (TAK), a venerable name in the healthcare sector, presents an intriguing investment opportunity primarily due to its expansive pipeline and robust market position. With a market..

UnitedHealth Group (UNH) Stock Analysis: Navigating Market Challenges with Strong Revenue Growth

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, continues to command investor interest despite recent market volatility. With a current market capitalization of $311.62 billion, UnitedHealth is..

Royalty Pharma (RPRX) Stock Analysis: Unlocking a 28% Upside Potential

Royalty Pharma plc (NASDAQ: RPRX), a pioneering entity in the biopharmaceutical royalty sphere, presents an intriguing opportunity for investors seeking both stability and growth within the healthcare sector. With a..

Centene Corporation (CNC) Stock Analysis: Navigating a 52-Week Range with Growth Insights

Centene Corporation (NYSE: CNC), a prominent player in the healthcare sector, is a key provider of healthcare plans in the United States. With a market capitalization of $17.12 billion, Centene..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Exploring a 51.46% Potential Upside in the Biotech Sector

Investors looking to capitalize on growth opportunities in the biotechnology sector might find Axsome Therapeutics, Inc. (NASDAQ: AXSM) an intriguing prospect. With a market cap of $5.83 billion, this New..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 17.64% Potential Upside Amid Robust Market Position

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, continues to attract investor attention with its strong market presence and promising financials. As a key player in..

Repligen Corporation (RGEN) Stock Analysis: 42.65% Potential Upside Ignites Investor Interest

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, particularly in the medical instruments and supplies industry, is capturing investor attention with a compelling potential upside of 42.65%...

Roivant Sciences Ltd. (ROIV) Stock Analysis: Navigating a 32% Potential Upside in the Biotech Sector

Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company, has been garnering significant attention from investors, particularly given its position in the rapidly evolving biotechnology sector. Based in London, United..

AptarGroup, Inc. (ATR) Stock Report: Analyzing a 33.69% Upside Potential for Investors

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector, stands out within the medical instruments and supplies industry. With a robust market capitalization of $8.72 billion, the company..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Unveiling a 13.95% Potential Upside in the Biotech Sector

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is garnering attention from investors with its promising 13.95% potential upside, making it a noteworthy player in the biotechnology sector. Headquartered in Carlsbad, California, Ionis..

Merck & Company, Inc. (MRK) Stock Analysis: A 29% Upside Potential Amid Strong Dividends

Merck & Company, Inc. (NYSE: MRK), a stalwart in the healthcare sector, is capturing investor attention with its combination of robust dividends and a notable upside potential. With a market..

Search

Funds

September 29, 2025

Search

Funds

September 29, 2025

FTSE 100

Funds